Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FZ0HX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,374
Award facts
- Contract value 100% obligated
- $3,374.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units, with a contract value of $3,374.46. This is a firm fixed-price delivery order issued on September 2, 2025, with completion scheduled for September 3, 2025. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. XELJANZ XR is a treatment for rheumatoid arthritis and other inflammatory conditions, representing part of the company's extensive portfolio of brand-name and generic pharmaceuticals supplied to federal medical procurement needs.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The DLA awards multiple delivery orders against this IDC to fulfill ongoing medication requirements for Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating AmerisourceBergen Drug Corp's critical role in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FZ0HX?
SPE2DB25FZ0HX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FZ0HX worth?
The government has obligated $3,374 on SPE2DB25FZ0HX.
Is contract SPE2DB25FZ0HX an order under another contract?
Yes. SPE2DB25FZ0HX is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ0HX competed?
The extent of competition for SPE2DB25FZ0HX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award